AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $181,573,994 | -3.1% | 14,934,021 | +0.1% | 0.12% | +1.7% |
Q2 2023 | $187,417,974 | +24.2% | 14,923,588 | +9.6% | 0.12% | +17.0% |
Q1 2023 | $150,935,079 | -9.7% | 13,610,435 | -0.6% | 0.10% | -16.0% |
Q4 2022 | $167,201,808 | +8.3% | 13,694,549 | -53.7% | 0.12% | +3.5% |
Q3 2022 | $154,421,267 | -14.3% | 29,552,230 | +76.1% | 0.12% | -7.3% |
Q2 2022 | $180,236,000 | +21.8% | 16,780,141 | +7.4% | 0.12% | +74.6% |
Q1 2022 | $147,957,000 | +29.9% | 15,622,613 | +58.5% | 0.07% | +51.1% |
Q4 2021 | $113,878,000 | +69.0% | 9,857,881 | +39.7% | 0.05% | +62.1% |
Q3 2021 | $67,378,000 | +40.1% | 7,054,208 | +41.4% | 0.03% | +38.1% |
Q2 2021 | $48,092,000 | -45.8% | 4,988,587 | -44.5% | 0.02% | -48.8% |
Q1 2021 | $88,762,000 | -65.8% | 8,984,055 | -20.1% | 0.04% | -66.1% |
Q4 2020 | $259,701,000 | +30.4% | 11,247,208 | -20.3% | 0.12% | +16.3% |
Q3 2020 | $199,181,000 | +12.0% | 14,106,259 | +19.6% | 0.10% | +4.0% |
Q2 2020 | $177,849,000 | +65.6% | 11,793,759 | +1.4% | 0.10% | +35.1% |
Q1 2020 | $107,423,000 | +2.5% | 11,625,924 | +8.1% | 0.07% | +37.0% |
Q4 2019 | $104,789,000 | +19.4% | 10,758,616 | -1.7% | 0.05% | +12.5% |
Q3 2019 | $87,789,000 | -35.3% | 10,946,235 | +0.7% | 0.05% | -35.1% |
Q2 2019 | $135,695,000 | -9.8% | 10,872,979 | -1.7% | 0.07% | -10.8% |
Q1 2019 | $150,363,000 | +41.7% | 11,056,142 | -0.2% | 0.08% | +22.1% |
Q4 2018 | $106,085,000 | -0.4% | 11,073,584 | +25.7% | 0.07% | +19.3% |
Q3 2018 | $106,469,000 | -16.7% | 8,806,359 | +7.7% | 0.06% | -21.9% |
Q2 2018 | $127,746,000 | -0.6% | 8,178,387 | -4.3% | 0.07% | -3.9% |
Q1 2018 | $128,537,000 | +12.8% | 8,546,339 | +8.0% | 0.08% | +8.6% |
Q4 2017 | $113,921,000 | +1.6% | 7,916,701 | +6.5% | 0.07% | -2.8% |
Q3 2017 | $112,109,000 | +58.4% | 7,434,314 | +5.8% | 0.07% | +50.0% |
Q2 2017 | $70,762,000 | – | 7,027,010 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |